Clinical Trial Update: Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients [Phase 3]

View source ↗

Summary

This clinical trial update reports the Phase 3 open study of lanthanum carbonate (BAY77-1931) in continuous ambulatory peritoneal dialysis patients with hyperph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

Sponsor: Bayer | Conditions: Hyperphosphatemia | Phase 3 | Status: COMPLETED